GeoPharma Announces Record Revenues in Third Quart...(December 31 December 31 ...)

2007 2006 2007 2006

Revenues:

PBM (a discontinued

operation) $-- $5,078,738 $-- $14,630,131

Distribution 11,217,987 3,374,219 14,435,258 9,869,392

Manufacturing 7,019,351 5,831,536 16,601,874 20,860,036

Pharmaceutical -- -- 41,188 251,845

Total revenues $18,237,338 $14,284,493 $31,078,320 $45,611,404

Cost of goods sold:

PBM (a discontinued

operation) -- 5,039,582 -- 14,515,619

Distribution 9,042,503 1,224,369 10,779,944 3,986,597

Manufacturing (excluding

depreciation and

amortization presented

below) 4,790,637 2,849,473 11,578,661 13,607,561

Pharmaceutical 828,743 654,640 2,402,125 813,571

Total cost of goods sold $14,661,883 $9,768,064 $24,760,730 $32,923,348

Gross profit:

PBM (a discontinued

operation) -- 39,156 -- 114,512

Distribution 2,175,484 2,149,850 3,655,314 5,882,795

Manufacturing 2,228,714 2,982,063 5,023,213 7,252,475

Pharmaceutical (828,743) (654,640) (2,360,937) (561,726)

Total gross profit $3,575,455 $4,516,429 $6,317,590 $12,688,056

Selling, general and

administrative expenses:

Selling, general and

administrative expenses 5,100,221 2,967,892 11,406,989 8,899,103

Stock option compensation

expense 266,658 427,675 687,495 1,283,025

Depreciation and

amortization 487,050 347,385 1,306,409 829,013

Selling, general and

administrative expenses
'/>"/>